Compugen Ltd

NASDAQ:CGEN

1.59

-0.10 (-5.92%)

6:05:25 PM EDT: $1.60 +0.01 (+0.63%)

Market Cap (Intraday)	139.88M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.95 Million
Adjusted EPS	-$0.06

See more estimates

10-Day MA	$1.68
50-Day MA	$1.56
200-Day MA	$1.69

See more pivots

Compugen Ltd Stock, NASDAQ:CGEN

Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858

Israel

Phone: +972.3.765.8585

Number of Employees: 74

http://www.cgen.com

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.